Dementia treatment: A number of new drugs for Alzheimer’s disease could soon be available
Dementia is a descend in mental ability, and Alzheimer’s disease is its most common type.
There are currently 44 million people surrounding the world who suffer from the debilitating condition, which can cause respect loss and problems thinking.
Despite the fact it costs the UK £26 billion a year, scientists make remained unable to successfully treat Alzheimer’s and other types of dementia.
Up to date month a clinical trial for a new drug to treat Alzheimer’s, intepirdine, forsook.
Dementia treatment: There hasn’t been a new Alzheimer’s panacea approved since 2003
There are currently only four drugs that clothed been approved to help Alzheimer’s, and the most recent got the go ahead 14 years ago in 2003.
There are currently just four drugs that have been approved to help Alzheimer’s, and the most new got the go ahead 14 years ago in 2003.
According to the Alzheimer’s Society, the medications familiar at the moment in the UK to help — but not cure — symptoms are donepezil, rivastigmine, galantamine and memantine.
Setting aside how, researchers believe that good news could soon be on its way, with inexperienced findings about potential new treatments expected to be published in 2018 and a indicate of new results anticipated for 2019.
It means that an effective cure for the condition could be agile in a matter of years.
1 of 8
Dementia treatment: So far scientists entertain not developed an effective cure for Alzheimer’s
Here are three future treatment opportunities on the horizon.
A drug to delay decline in people with mild Alzheimer’s
Checks are being done on an Alzheimer’s drug, that has been in the pipeline for 17 years, that could dawdling cognitive decline in people who have started to show signs of the condition.
It’s phase 3 trial — the latest stage of a clinical trial before American companies adduce to the US’s Food and Drug Administration (FDA) — is predicted to be completed by 2018.
Dementia treatment: It expenses the UK £26 billion a year
A drug to prevent Alzheimer’s before it’s neck begun
Research has shown that Alzheimer’s starts years rather than symptoms even begin to show.
Amyloid beta deposits in the thought slowly accumulate and build up into plaques, leading to symptoms.
A review by the University of Antioquia in Colombia are currently testing an amyloid-related drug on 300 associates of an extended family who have a rare genetic mutation that precipitates early-onset Alzheimer’s.
A drug to clear out Alzheimer’s-causing plaque shape up
Biogen, an American company, is developing a drug that treats the working order by clearing amyloid deposits in the brain out the way.
They are expected to announce terminates in 2019 or early 2020.
Several other companies are also following what has chance upon to be known as the “amyloid hypothesis”.